Pfizer launching first US mAb biosimilar with Remicade knockoff, but you can forget about any fire sale
Pfizer $PFE plans to launch the first mAb copycat and the second biosimilar ever in the US in the next few weeks. But the price …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
